Pherecydes Pharma
Operator of an innovative biotechnologies company created to develop personalized phage therapy.
Launch date
Employees
Market cap
-
Enterprise valuation
€35—52m (Dealroom.co estimates Jan 2018.)
Company register number 493252266
Nantes Pays de la Loire (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | €900k | Grant | |
€1.9m | Series A | ||
* | €8.7m | Series B | |
€2.5m | Grant | ||
| N/A | N/A | IPO | |
€2.0m | Grant | ||
* | €3.1m | Post IPO Equity | |
* | N/A | Merger | |
| Total Funding | €16.0m | ||
Related Content
Recent News about Pherecydes Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Pherecydes Pharma
Edit
exited